Terms: = Lung cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Prognosis
18 results:
1. Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy.
Wu Y; Lv C; Lin M; Hong Y; Du B; Yao N; Zhu Y; Ji X; Li J; Lai J
Front Immunol; 2023; 14():1297188. PubMed ID: 38022521
[TBL] [Abstract] [Full Text] [Related]
2. The predictive value of the change of the number of pixels under different CT value intervals in the CT-occult central lung squamous cell carcinoma and squamous epithelial precancerous lesions.
Zhou J; Yu B; Guo P; Wang S
BMC Pulm Med; 2023 Nov; 23(1):426. PubMed ID: 37924039
[TBL] [Abstract] [Full Text] [Related]
3. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
[TBL] [Abstract] [Full Text] [Related]
4. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract] [Full Text] [Related]
5. A novel analytical approach for outcome prediction in newly diagnosed NSCLC based on [
Zhang L; Xu C; Zhang X; Wang J; Jiang H; Chen J; Zhang H
Eur Radiol; 2023 Mar; 33(3):1757-1768. PubMed ID: 36222865
[TBL] [Abstract] [Full Text] [Related]
6. Survival Prediction in Home Hospice Care Patients with lung cancer Based on LASSO Algorithm.
Zeng Y; Cao W; Wu C; Wang M; Xie Y; Chen W; Hu X; Zhou Y; Jing X; Cai X
Cancer Control; 2022; 29():10732748221124519. PubMed ID: 36039467
[TBL] [Abstract] [Full Text] [Related]
7. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
[TBL] [Abstract] [Full Text] [Related]
8. Impact of Site-Specific Metastases on Surgical Value and Survival among Metastatic Colorectal cancer Patients.
Zong Z; Zhou TC; Tang FX; Tian HK; Wang A; Yi CH
Am Surg; 2020 Mar; 86(3):220-227. PubMed ID: 32223801
[TBL] [Abstract] [Full Text] [Related]
9. A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell lung cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network.
Xie H; Xie C
Biomed Res Int; 2019; 2019():4250613. PubMed ID: 31886214
[No Abstract] [Full Text] [Related]
10. Prediction of chemotherapy adverse reactions and mortality in older patients with primary lung cancer through frailty index based on routine laboratory data.
Wang Y; Zhang R; Shen Y; Su L; Dong B; Hao Q
Clin Interv Aging; 2019; 14():1187-1197. PubMed ID: 31308642
[TBL] [Abstract] [Full Text] [Related]
11. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
[TBL] [Abstract] [Full Text] [Related]
12. Computer-aided Volumetry of Part-Solid lung cancers by Using CT: Solid Component Size Predicts prognosis.
Kamiya S; Iwano S; Umakoshi H; Ito R; Shimamoto H; Nakamura S; Naganawa S
Radiology; 2018 Jun; 287(3):1030-1040. PubMed ID: 29533722
[TBL] [Abstract] [Full Text] [Related]
13. Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.
Rosen LE; Karrison T; Ananthanarayanan V; Gallan AJ; Adusumilli PS; Alchami FS; Attanoos R; Brcic L; Butnor KJ; Galateau-Sallé F; Hiroshima K; Kadota K; Klampatsa A; Stang NL; Lindenmann J; Litzky LA; Marchevsky A; Medeiros F; Montero MA; Moore DA; Nabeshima K; Pavlisko EN; Roggli VL; Sauter JL; Sharma A; Sheaff M; Travis WD; Vigneswaran WT; Vrugt B; Walts AE; Tjota MY; Krausz T; Husain AN
Mod Pathol; 2018 Apr; 31(4):598-606. PubMed ID: 29327706
[TBL] [Abstract] [Full Text] [Related]
14. Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.
Wu S; Zhao X; Wu S; Du R; Zhu Q; Fang H; Zhang X; Zhang C; Zheng W; Yang J; Feng H
Oncotarget; 2016 Dec; 7(49):81750-81756. PubMed ID: 27835582
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptome Analysis of WHV/c-myc Transgenic Mice Implicates Cytochrome P450 Enzyme 17A1 as a Promising Biomarker for Hepatocellular Carcinoma.
Wang F; Huang J; Zhu Z; Ma X; Cao L; Zhang Y; Chen W; Dong Y
Cancer Prev Res (Phila); 2016 Sep; 9(9):739-49. PubMed ID: 27339169
[TBL] [Abstract] [Full Text] [Related]
16. Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival.
Wilgus ML; Borczuk AC; Stoopler M; Ginsburg M; Gorenstein L; Sonett JR; Powell CA
Cancer; 2011 May; 117(10):2186-91. PubMed ID: 21523732
[TBL] [Abstract] [Full Text] [Related]
17. Renal cell carcinoma as first and second primary cancer: etiological clues from the Swedish Family-cancer Database.
Liu H; Hemminki K; Sundquist J
J Urol; 2011 Jun; 185(6):2045-9. PubMed ID: 21496838
[TBL] [Abstract] [Full Text] [Related]
18. Differential pattern of DNA-aneuploidy in human malignancies.
Büchner T; Hiddemann W; Wörmann B; Kleinemeier B; Schumann J; Göhde W; Ritter J; Müller KM; von Bassewitz DB; Roessner A
Pathol Res Pract; 1985 Jan; 179(3):310-7. PubMed ID: 3856834
[TBL] [Abstract] [Full Text] [Related]